Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
B9 domain-containing protein 2 (B9D2) is a highly conserved ciliary protein found exclusively in ciliated organisms[1][4][5]. It localizes primarily to the transition zone at the base of cilia, where it forms a critical heterotrimeric complex with MKS1 and B9D1[1][3][4][5]. This complex serves as a selective diffusion barrier for ciliary membrane proteins, facilitating compartmentalization of signaling pathways such as Hedgehog signaling and playing a decisive role in ciliogenesis and ciliary membrane organization[1][3][4][5]. Loss of B9D2 disrupts the formation and maintenance of both motile and primary cilia, resulting in severe multi-organ developmental defects associated with ciliopathies including Meckel-Gruber syndrome and Joubert syndrome[1][2]. Beyond its ciliary functions, B9D2 is crucial for the maturation and maintenance of epithelial tight junctions and cell polarity, impacting tissue architecture during development (notably in the liver)[2]. There are no known therapeutic drugs or direct modulators targeting B9D2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B9 domain-containing protein 2 (B9D2).